03/04
Headlines

Healthcare Most Volatile: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), OXiGENE Inc (NASDAQ:OXGN), Intrexon (NYSE:XON), Enzon Pharmaceuticals (NASDAQ:ENZN)

John Bellich02 mins

Idenix Pharmaceuticals (NASDAQ:IDIX) , which had its hepatitis C drugs put on clinical hold because it had a similar structure to Bristol-Myers Squibb’s BMS-986094, which had serious cardiac side effects. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was -6.45% in last session and finished the day at $7.11. Traded volume was 3,306,727 million shares in the…

Read More

Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

Colin Pettis02 mins

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of Illumina stock in a transaction that occurred on Monday, March 17th. Illumina, Inc. (NASDAQ:ILMN) stock performance was -5.42% in last session and finished the day at $152.60. Traded volume was 4,483,791 million shares in the last session and the average volume of the stock remained 1.99…

Read More

Healthcare New Highs: UnitedHealth Group Inc. (NYSE:UNH), WellPoint Inc (NYSE:WLP), Insulet Corporation (NASDAQ:PODD), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Colin Pettis02 mins

UnitedHealth Group (NYSE:UNH) rose 7.45% last week, as health-care providers are starting to see increased membership, thanks to the Affordable Care Act. UnitedHealth competitor WellPoint, in particular, increased its full-year guidance this past week and expects more than 1 million new health plan members this year. UnitedHealth Group Inc. (NYSE:UNH) stock performance was -0.23% in…

Read More

Healthcare Bullish Stocks: Biota Pharmaceuticals (NASDAQ:BOTA), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Vermillion (NASDAQ:VRML), Genetic Technologies (NASDAQ:GENE)

Jason Knox02 mins

Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) presented an update on the company at the 26th Annual ROTH Conference at 12:30 p.m. PDT, March 11, 2014, at The Ritz-Carlton, Dana Point in California. Biota Pharmaceuticals Inc (NASDAQ:BOTA) stock performance was 10.15% in last session and finished the day at $6.62. Traded volume was 449,674 million shares in the…

Read More

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

John Meady02 mins

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the…

Read More

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman02 mins

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓